GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » Cyclically Adjusted PS Ratio

Albert David (BOM:524075) Cyclically Adjusted PS Ratio : 1.72 (As of Jan. 18, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Albert David Cyclically Adjusted PS Ratio?

As of today (2025-01-18), Albert David's current share price is ₹1215.30. Albert David's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was ₹708.30. Albert David's Cyclically Adjusted PS Ratio for today is 1.72.

The historical rank and industry rank for Albert David's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524075' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.57   Med: 0.86   Max: 2.29
Current: 1.73

During the past years, Albert David's highest Cyclically Adjusted PS Ratio was 2.29. The lowest was 0.57. And the median was 0.86.

BOM:524075's Cyclically Adjusted PS Ratio is ranked better than
61.72% of 640 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs BOM:524075: 1.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Albert David's adjusted revenue per share data for the three months ended in Sep. 2024 was ₹172.512. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹708.30 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Albert David Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Albert David's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David Cyclically Adjusted PS Ratio Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.57 0.78 0.73 1.53

Albert David Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.38 1.53 1.93 2.04

Competitive Comparison of Albert David's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Albert David's Cyclically Adjusted PS Ratio falls into.



Albert David Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Albert David's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1215.30/708.3
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert David's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Albert David's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=172.512/157.8822*157.8822
=172.512

Current CPI (Sep. 2024) = 157.8822.

Albert David Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 133.278 96.780 217.422
201503 121.910 97.163 198.094
201506 148.755 99.841 235.233
201509 172.263 101.753 267.286
201512 128.100 102.901 196.546
201603 121.355 102.518 186.891
201606 139.615 105.961 208.027
201609 159.500 105.961 237.655
201612 102.932 105.196 154.484
201703 122.566 105.196 183.952
201706 95.772 107.109 141.171
201709 160.012 109.021 231.726
201712 130.744 109.404 188.678
201803 121.086 109.786 174.132
201806 165.457 111.317 234.671
201809 136.001 115.142 186.484
201812 134.829 115.142 184.877
201903 111.326 118.202 148.698
201906 160.544 120.880 209.688
201909 156.993 123.175 201.229
201912 139.354 126.235 174.290
202003 101.035 124.705 127.915
202006 94.134 127.000 117.024
202009 125.613 130.118 152.416
202012 114.388 130.889 137.978
202103 97.445 131.771 116.755
202106 142.083 134.084 167.301
202109 151.259 135.847 175.794
202112 125.655 138.161 143.591
202203 128.441 138.822 146.076
202206 163.504 142.347 181.348
202209 161.895 144.661 176.691
202212 130.662 145.763 141.526
202303 139.942 146.865 150.440
202306 161.113 150.280 169.263
202309 163.266 151.492 170.153
202312 154.689 152.924 159.704
202403 151.797 153.035 156.605
202406 156.573 155.789 158.677
202409 172.512 157.882 172.512

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Albert David  (BOM:524075) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Albert David Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Albert David's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David Headlines

No Headlines